Built by former payers, HTA reviewers, and Industry Experts.
About Us
Where We Started
MARA Rating Company was founded in 2020 by former HTA assessors, payers, and investment-bank analysts who saw billion-dollar deals falter on unrealistic pricing and reimbursement assumptions. Building on decades of combined experience at NICE, ICER, and global-pharma BD and Market Access teams, we set out to bring the rigor of credit rati
MARA Rating Company was founded in 2020 by former HTA assessors, payers, and investment-bank analysts who saw billion-dollar deals falter on unrealistic pricing and reimbursement assumptions. Building on decades of combined experience at NICE, ICER, and global-pharma BD and Market Access teams, we set out to bring the rigor of credit ratings to market-access risk—so capital is deployed with eyes wide open.
Why We Exist
Our mission is to make life-science investments more predictable and patient access more efficient. We deliver transparent, data-driven ratings that quantify pricing and reimbursement risk, empowering companies and investors to move decisively—whether that means acquiring, partnering, or reallocating capital.
Our Values
Our Values
- Independence: Free from advisory conflicts—our ratings speak only to the evidence.
- Evidence First: Proprietary payer data and HTA analytics underpin every score.
- Impact-Driven: We measure success by smarter deals and faster patient access.
